Rationale for cancer prevention stragies in high-risk ulce colitis

Surgeon

Volumn 7, Issue 2, 2009, Pages 96-100

  Campbell, F C ^a   Maxwell, R J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cancer; Clonality; Colitis; Inflammatio

Indexed keywords

EID: 65349127216     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(09)80024-3     Document Type: Review

References (46)

1. Bargan J A. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928; 17: 561-65
2. Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996; 91: 44-48
3. Solomon MJ, Schnitzler M. Cancer and inflammatory bowel disease: bias, epidemiology, surveillance, and treatment. World J Surg 1998; 22: 352-58
4. E6kbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33
5. Langholz E, Munkholm P, Davidsen M et al. Colorec-tal cancer risk and mortality in patients with ulcer-ative colitis. Gastroenterology 1992; 103: 1444-51
6. FonagerK, Sorensen HT, Mellemkjaer L et al. Risk of colorectal cancer in relatives of patients with inflammatory bowel disease (Denmark). Cancer Causes Control 1998; 9: 389-92
7. Gupta RB, Harpaz N, Itzkowitz S et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007; 133: 1099-105; quiz 1340-1
8. Perwez Hussain S, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007; 121: 2373-80
9. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997; 41: 522-25
10. Orii S et al. Chemoprevention for colorectal tumori-genesis associated with chronic colitis in mice via apoptosis. j Exp Clin Cancer Res 2003; 22: 41-46
11. Limoli CL, Giedzinski E. Induction of chromosomal instability by chronic oxidative stress. Neoplasia 2003; 5: 339-46
12. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-17
13. Willenbucher RF, Aust DE, Chang CG et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 1999; 154: 1825-30
14. Panja A, Goldberg S, Eckmann L et al. The regula-tion and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol 1998; 161: 3675-84
15. Farber E. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res 1995; 55: 3759-62
16. Ledda-Columbano GM, Coni P, Curto M et al. Mito-gen-induced liver hyperplasia does not substitute for compensatory regeneration during promotion of chemical hepatocarcinogenesis. Carcinogenesis 1992; 13: 379-83
17. Ledda-Columbano GM, Coni P, Simbula G et al. Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perspect 1993; 101 Suppl 5: 163-68
18. Patel HR, Tait IS, Evans GS et al. Influence of cell interactions in a novel model of postnatal mucosal regeneration. Gut 1996; 38: 679-86
19. Potten CS. Regeneration in epithelial proliferative units as exemplified by small intestinal crypts. Ciba Found Symp 1991; 160: 54-71; discussion 71-76
20. Okayasu I, Yamada M, Mikami T et al. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroen-terol Hepatol 2002; 17: 1078-83
21. Heinen CD, Noffsinger AE, Belli J et al. Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chromosomes Cancer 1997; 19: 170-75
22. Patel HR, Hewer A, Phillips DH et al. Metabolic competence and susceptibility of intestinal epithelium to genotoxic injury during regeneration. Carcinogenesis 1997; 18: 2171-77
23. Donnelly ET, Bardwell H, Thomas GA et al. Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical. Carcinogenesis 2004; 25: 847-55
24. Donnelly ET, Bardwell H, Thomas GA et al. Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. Br J Cancer 2005; 92: 2160-65
25. Ahnen Dj. Abnormal DNA content as a biomarker of large bowel cancer risk and prognosis. ] Cell Biochem Suppl 1992; i6G: 143-50
26. Connell WR, Talbot IC, Hapaz N et al. Clinicopatho- logical characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35: 1419-23
27. Vonherbay AHC, Otto HF. Cancer and dysplasia In ulcerative colitis - a histologic study of 301 surgical specimens. Zeitschrift Fur Gastroenterologie 1994; 32: 382-8
28. Connell WR, Lennard-Jones JE, Talbot IC et al. Low grade dysplasia is an important predictive marker of malignancy or high grade dysplasia in ulcerative colitis. Gastroenterology 1996; 106: A667 (1996)
29. Rabinovitch PS, Dziadon S, BrentnallTAetal. Panco- lonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999; 59: 5148-53
30. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51: Suppl 5, V10-2
31. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 314-21
32. Shivananda S et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-97
33. Stonnington CM, Phillips SF, Melton LJ et al. Chronic ulcerative colitis: incidence and prevalence in a community. Gut 1987; 28: 402-9
34. Lynch DA, Lobo AJ, Sobala GM et al. Failure of colonoscopic surveillance in ulcers^ive colitis. Gut 1993; 34: 1075-80
35. Mayer R, Wong WD, Rothenberger DA et al. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum 1999; 42: 343-47
36. Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-88
37. Connell WR, Lennard-Jones JE, Williams CB et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-44
38. Ullman T, Croog V, Harpaz N et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003; 125: 1311-19
39. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71-74
40. Lim CH, Dixon MF, Vail A et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003; 52: 1127-32
41. Johnson WR, McDermott FT, Hughes ES et al. The risk of rectal carcinoma following colectomy in ulcerative colitis. Dis Colon Rectum 1983; 26: 44-46
42. Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Cut 2001; 48: 430-34
43. Gurbuz AK, Giardiello FM, Bayless TM. Colore tal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995; 38: 37-41
44. Brentnall TA et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331-38
45. Sandborn W), Loftus EV Jr, Ahlquist DA. Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: is it true and does it matter? Gastroenterology 1998; 115: 236-37
46. Jasani B, Campbell F, Navabi H et al. Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. J Pathol 1998; 184: 144-47